CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioNano Genomics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioNano Genomics Inc
9640 TOWNE CENTRE DRIVE
9640 TOWNE CENTRE DRIVE
Phone: (858) 888-7600p:858 888-7600 SAN DIEGO, CA  92121  United States Ticker: BNGOBNGO
Business Summary
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board David L.Barker 81 8/1/2016 5/1/2010
President, Chief Executive Officer, Director R. ErikHolmlin 55 1/1/2011 1/1/2011
Chief Financial Officer GulsenKama 50 9/11/2023 9/11/2023
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Purigen Biosystems, Inc. 5700 Stoneridge Dr Pleasanton CA United States
BioDiscovery, Inc. 715 North Douglas Street El Segundo California United States
LineaGen, Inc. 2677 E Parleys Way Salt Lake City UT United States

Business Names
Business Name
BioDiscovery, Inc.
BioDiscovery, Inc.
BioNano Genomics (Shanghai) Trading Co., Ltd.
8 additional Business Names available in full report.

General Information
Number of Employees: 344 (As of 12/31/2023)
Outstanding Shares: 52,288,682 (As of 4/4/2024)
Shareholders: 62
Stock Exchange: NASD
Federal Tax Id: 261756290
Fax Number: (858) 888-7601
Email Address: info@bionanogenomics.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024